Terms: = Sarcomas AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
67 results:
1. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
Lin Y; Cao Q; Hong A; Liang X
Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
[TBL] [Abstract] [Full Text] [Related]
2. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/fus-mediated mRNA of ZNFX1.
Wang Z; She D; Liu L; Hua X; Zhu H; Yu L; Wang H; Zhu Y; Fan G; Wang Y; Xu M; Zhou G
Cell Signal; 2024 Feb; 114():110977. PubMed ID: 37984605
[TBL] [Abstract] [Full Text] [Related]
4. Hyperhidrosis as the initial symptom in fus mutation-associated amyotrophic lateral sclerosis: a case report and comprehensive literature review.
Chen X; Luo J; Zheng W; Huang Q; Du C; Yuan H; Xiao F
Neurol Sci; 2024 Apr; 45(4):1523-1527. PubMed ID: 37904013
[TBL] [Abstract] [Full Text] [Related]
5. First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma.
Benitez-Escobar EN; Galindes-Casanova DA; Melo-Burbano LÁ; Bonilla-Bonilla DM; Osorio-Toro LM; Daza-Arana JE; Escobar-Dávila SL; Rivas-Tafurt GP
Chin Clin Oncol; 2023 Aug; 12(4):45. PubMed ID: 37599513
[TBL] [Abstract] [Full Text] [Related]
6. Expression of IL-13Rα2 and fus in glioma: clinicopathological and prognostic correlation.
Cheng G; Wang M; Zhang X; Zhang Y
BMC Neurol; 2023 May; 23(1):185. PubMed ID: 37158824
[TBL] [Abstract] [Full Text] [Related]
7. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
Quesada S; Lebreton C; Caux C; Italiano A; Dubois B
Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
9. RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
Yang Y; Shu Y; Tang Y; Zhao S; Jia Y; Ji J; Ma H; Lin T; Zheng K; Xu H; Wu Y
Cancer Med; 2023 Apr; 12(8):9156-9166. PubMed ID: 36916780
[TBL] [Abstract] [Full Text] [Related]
10. Hypoxia-Induced fus-circTBC1D14 Stress Granules Promote Autophagy in TNBC.
Liu Y; Liu Y; He Y; Zhang N; Zhang S; Li Y; Wang X; Liang Y; Chen X; Zhao W; Chen B; Wang L; Luo D; Yang Q
Adv Sci (Weinh); 2023 Apr; 10(10):e2204988. PubMed ID: 36806670
[TBL] [Abstract] [Full Text] [Related]
11. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging
Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836
[TBL] [Abstract] [Full Text] [Related]
12. Autophagy inhibition and reactive oxygen species elimination by acetyl-CoA acetyltransferase 1 through fused in sarcoma protein to promote prostate cancer.
Guan J; Jiang X; Guo Y; Zhao W; Li J; Li Y; Cheng M; Fu L; Zhao Y; Li Q
BMC Cancer; 2022 Dec; 22(1):1313. PubMed ID: 36517760
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
Duan FL; Yang H; Gong X; Zuo Z; Qin S; Ji J; Zhou C; Dai J; Guo P; Liu Y
Histopathology; 2023 Feb; 82(3):478-484. PubMed ID: 36350070
[TBL] [Abstract] [Full Text] [Related]
14. circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with fus to stabilize FOXR2.
Liang YX; Zhang LL; Yang L
Mol Cell Biochem; 2023 Apr; 478(4):835-850. PubMed ID: 36107285
[TBL] [Abstract] [Full Text] [Related]
15. Superficial low-grade fibromyxoid sarcoma.
Ronen S; Ko JS; Rubin BP; Kilpatrick SE; Wang WL; Lazar AJ; Goldblum JR; Billings SD
J Cutan Pathol; 2023 Feb; 50(2):147-154. PubMed ID: 36074249
[TBL] [Abstract] [Full Text] [Related]
16. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Ono T; Akiyama T; Hirabayashi K; Ozawa I; Nakagawa R; Kikuta K; Kondo T
Hum Cell; 2022 Jul; 35(4):1279-1289. PubMed ID: 35637403
[TBL] [Abstract] [Full Text] [Related]
17. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and tls-ERG gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
18. High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis.
Kunieda J; Yamashita K; Togashi Y; Baba S; Sakata S; Inamura K; Ae K; Matsumoto S; Machinami R; Kitagawa M; Takeuchi K
Cancer Sci; 2022 Mar; 113(3):1078-1089. PubMed ID: 34971481
[TBL] [Abstract] [Full Text] [Related]
19. Improving Immunotherapy Efficacy in Soft-Tissue sarcomas: A Biomarker Driven and Histotype Tailored Review.
Roulleaux Dugage M; Nassif EF; Italiano A; Bahleda R
Front Immunol; 2021; 12():775761. PubMed ID: 34925348
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of fus immunoexpression for Gleason patterns and prostatic adenocarcinoma progression.
Hirth CG; Vasconcelos GR; Lima MVA; da Cunha MDPSS; Frederico IKS; Dornelas CA
Ann Diagn Pathol; 2021 Jun; 52():151729. PubMed ID: 33713944
[TBL] [Abstract] [Full Text] [Related]
[Next]
